ADUS
Addus HomeCare Corporation
ADUS's fundamentals are strong and it looks cheap: trading at 21x earnings, below its usual 30x. Analysts expect earnings growth.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
ADUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ADUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
ADUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $124 | — |
| Current | 21x | $124 | — |
| Cheap | 24x | $146 | +18% |
| Fair | 30x | $180 | +46% |
| Expensive | 48x | $286 | +131% |
Historical ranges are pointers, not guarantees.
ADUS's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
ADUS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
ADUS has the edge over HIMS on the outlook, with more favorable earnings expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
ADUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.47 | +24% |
| Q3 2026 | $6.01 | +29% |
| Q2 2026 | $5.71 | +26% |
| Q1 2026 | $5.42 | +23% |
| Q4 2025 | $5.22 | +23% |
| Q3 2025 | $4.66 | +6.9% |
| Q2 2025 | $4.52 | +7.4% |
| Q1 2025 | $4.42 | +10% |
| Q4 2024 | $4.23 | +10% |
ADUS has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
ADUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $387.7M | +7% |
| Q2 2026 | $377.4M | +8% |
| Q1 2026 | $363.6M | +7.7% |
| Q4 2025 | $373.1M | +26% |
| Q3 2025 | $362.3M | +25% |
| Q2 2025 | $349.4M | +22% |
| Q1 2025 | $337.7M | +20% |
| Q4 2024 | $297.1M | +7.5% |
ADUS's revenue has grown year over year every quarter since late 2020: $388M last quarter, up 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +1.2 points |
| Q2 2026 | 10% | +0.9 points |
| Q1 2026 | 9.4% | +0.3 points |
| Q4 2025 | 11% | +2.3 points |
| Q3 2025 | 9.1% | +0.1 points |
| Q2 2025 | 9.4% | +0.3 points |
| Q1 2025 | 9% | +0.6 points |
| Q4 2024 | 9.1% | -1.1 points |
ADUS has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over ADUS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
ADUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $38.8M | -21% |
| Q2 2026 | $38.7M | +82% |
| Q1 2026 | $50.7M | +197% |
| Q4 2025 | $16.1M | +85% |
| Q3 2025 | $49.3M | +5.9% |
| Q2 2025 | $21.3M | +20% |
| Q1 2025 | $17.1M | -54% |
| Q4 2024 | $8.7M | -65% |
ADUS generated $144M in free cash flow over the past year, up 50% from the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over ADUS on cash flow, with more consistent year-over-year improvement.
ADUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +102K shares |
| 1 year | +1% | +184K shares |
| 3 years | +14% | +2.3M shares |
| 5 years | +16% | +2.5M shares |
| Available history | +17% | +2.7M shares |
ADUS has 19M diluted shares, up 1% from a year ago.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over ADUS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
ADUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
ADUS has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
ADUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.4 | Neutral |
| Stochastic | 75.9 | Neutral |
ADUS's weekly RSI is 63 (neutral) and its Stochastic is 76 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
ADUS PE vs Healthcare Sector
| Metric | ADUS | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 26x | 20% below |
| PE % | 8 | 29 | 21 pts below |
ADUS is trading at 21x earnings, a 20% discount to the Healthcare sector's median of 26x.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
ADUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $118.8 | 4.2% above |
| 20 week MA | $116.7 | 6.1% above |
| 50 week MA | $107.7 | 15% above |
| 100 week MA | $110.0 | 13% above |
| 200 week MA | $106.5 | 16% above |
ADUS has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
ADUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $95.6 | $115.2 | +21% |
| 2021 | $115.2 | $93.3 | -19% |
| 2022 | $93.3 | $101.0 | +8.2% |
| 2023 | $101.0 | $92.9 | -8% |
| 2024 | $92.9 | $128.2 | +38% |
| 2025 | $128.2 | $110.2 | -14% |
| 2026 YTD | $110.2 | $123.7 | +12% |
ADUS has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.